United States

People: Agenus Inc (AGEN.O)

AGEN.O on Consolidated Issue listed on NASDAQ Capital Market

28 Apr 2017
Change (% chg)

$-0.09 (-2.45%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Armen, Garo 

Dr. Garo H. Armen, Ph.D., is a founder and serves as Chairman of the Board, Chief Executive Officer of Agenus Inc. Dr. Armen brings to our Board a deep historical and practical knowledge of the business of the Company and its technologies, as well as years of expertise in the financial and biopharmaceutical arenas. From mid-2002 through 2004, he was Chairman of the Board of Directors for the biopharmaceutical company Elan Corporation, plc which he helped restructure. Dr. Armen currently serves as non-executive Chairman of the Board of Directors of Protagenic Therapeutics, Inc., a privately held biotechnology company. Dr. Armen is also the founder and Chairman of the Children of Armenia Fund, a philanthropic organization established in 2000 that is dedicated to the positive development of the children and youth of rural Armenia. He holds a Ph.D. degree in physical organic chemistry from the City University of New York.

Basic Compensation

Total Annual Compensation, USD 922,360
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,361,170
Fiscal Year Total, USD 2,283,530

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --